Logo image
Genome-wide siRNA screen reveals coupling between mitotic apoptosis and adaptation
Journal article   Open access   Peer reviewed

Genome-wide siRNA screen reveals coupling between mitotic apoptosis and adaptation

Laura A Díaz-Martínez, Zemfira N Karamysheva, Ross Warrington, Bing Li, Shuguang Wei, Xian-Jin Xie, Michael G Roth and Hongtao Yu
The EMBO journal, Vol.33(17), pp.1960-1976
09/01/2014
DOI: 10.15252/embj.201487826
PMCID: PMC4195789
PMID: 25024437
url
https://europepmc.org/articles/pmc4195789View
Published (Version of record) Open Access

Abstract

The antimitotic anti-cancer drugs, including taxol, perturb spindle dynamics, and induce prolonged, spindle checkpoint-dependent mitotic arrest in cancer cells. These cells then either undergo apoptosis triggered by the intrinsic mitochondrial pathway or exit mitosis without proper cell division in an adaptation pathway. Using a genome-wide small interfering RNA (siRNA) screen in taxol-treated HeLa cells, we systematically identify components of the mitotic apoptosis and adaptation pathways. We show that the Mad2 inhibitor p31(comet) actively promotes mitotic adaptation through cyclin B1 degradation and has a minor separate function in suppressing apoptosis. Conversely, the pro-apoptotic Bcl2 family member, Noxa, is a critical initiator of mitotic cell death. Unexpectedly, the upstream components of the mitochondrial apoptosis pathway and the mitochondrial fission protein Drp1 contribute to mitotic adaption. Our results reveal crosstalk between the apoptosis and adaptation pathways during mitotic arrest.
Mitosis Apoptosis Adaptation, Physiological RNA, Small Interfering - genetics Paclitaxel - pharmacology Epithelial Cells - drug effects Humans Antineoplastic Agents - pharmacology Gene Expression Profiling RNA, Small Interfering - analysis HeLa Cells Epithelial Cells - cytology

Details

Metrics

Logo image